We are live on ! Find out more
CAC

Core Alternative Capital Portfolio holdings

AUM $339M
1-Year Est. Return 18.22%
This Fund
S&P 500
This Quarter Est. Return
+8%
1 Year Est. Return
+18.22%
3 Year Est. Return
+57.45%
5 Year Est. Return
+82.24%
10 Year Est. Return
AUM
$517M
AUM Growth
+$17.1M
Cap. Flow
-$16.3M
Cap. Flow %
-3.16%
Top 10 Hldgs %
31.98%
Holding
367
New
4
Increased
25
Reduced
78
Closed
6

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$3.67M
2
XOM icon
ExxonMobil
XOM
+$3.52M
3
WM icon
Waste Management
WM
+$3.51M
4
WMT icon
Walmart Inc
WMT
+$3.44M
5
CME icon
CME Group
CME
+$312K

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$2.06M
2
AFL icon
Aflac
AFL
+$1.37M
3
JPM icon
JPMorgan Chase
JPM
+$1.21M
4
FISV
Fiserv Inc
FISV
+$1.15M
5
AAPL icon
Apple
AAPL
+$1.14M

Sector Composition

Rank Sector Weight
1 Technology 25.52%
2 Financials 15.43%
3 Healthcare 11.4%
4 Consumer Staples 8.87%
5 Industrials 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVR icon
126
Evercore
EVR
$13.1B
$79.8K 0.02%
315
GS icon
127
Goldman Sachs
GS
$313B
$74.3K 0.01%
150
CL icon
128
Colgate-Palmolive
CL
$72.6B
$70.2K 0.01%
676
GE icon
129
GE Aerospace
GE
$367B
$70.2K 0.01%
372
RS icon
130
Reliance Steel & Aluminium
RS
$20.8B
$69.7K 0.01%
241
FTNT icon
131
Fortinet
FTNT
$112B
$65.5K 0.01%
845
GD icon
132
General Dynamics
GD
$105B
$64.4K 0.01%
213
+150
+238% +$44.1K
ABT icon
133
Abbott
ABT
$180B
$63.4K 0.01%
556
TYL icon
134
Tyler Technologies
TYL
$12.2B
$61.3K 0.01%
105
VRTX icon
135
Vertex Pharmaceuticals
VRTX
$121B
$60.9K 0.01%
131
ELV icon
136
Elevance Health
ELV
$81.9B
$59.8K 0.01%
115
CARR icon
137
Carrier Global
CARR
$57.2B
$59.6K 0.01%
741
YUM icon
138
Yum! Brands
YUM
$41B
$56.7K 0.01%
406
XPO icon
139
XPO
XPO
$25B
$54.3K 0.01%
505
VIG icon
140
Vanguard Dividend Appreciation ETF
VIG
$111B
$51.7K 0.01%
261
NTES icon
141
NetEase
NTES
$76.5B
$51K 0.01%
545
RSP icon
142
Invesco S&P 500 Equal Weight ETF
RSP
$96.1B
$49.3K 0.01%
275
ADBE icon
143
Adobe
ADBE
$89.5B
$48.7K 0.01%
94
CPRT icon
144
Copart
CPRT
$25.9B
$47.8K 0.01%
912
REGN icon
145
Regeneron Pharmaceuticals
REGN
$68.8B
$45.2K 0.01%
43
EME icon
146
Emcor
EME
$33.1B
$42.6K 0.01%
99
CRM icon
147
Salesforce
CRM
$134B
$41.9K 0.01%
153
TDG icon
148
TransDigm Group
TDG
$69.2B
$40K 0.01%
28
QCOM icon
149
Qualcomm
QCOM
$176B
$39.1K 0.01%
230
TMUS icon
150
T-Mobile US
TMUS
$193B
$36.5K 0.01%
177

Similar funds

Core Alternative Capital's Q3 2024 Portfolio in Review

As of Q3 2024, Core Alternative Capital held 367 positions worth $517M, up 3.4% from $500M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Core Alternative Capital withdrew a net $16.3M in Q3 2024, closing 6 positions and reducing 78 holdings. Its most notable exit was Gabelli Dividend & Income Trust 5.375% Series H Preferred Shares, an estimated $17.5K position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Core Alternative Capital opened a new position in iShares Russell Mid-Cap ETF worth $16.7K.

  • Core Alternative Capital's largest Q3 2024 buy was iShares Russell Mid-Cap ETF: 190 shares worth $16.7K.
  • Core Alternative Capital added most to UnitedHealth in Q3 2024, an estimated $3.67M increase.
  • Core Alternative Capital's biggest Q3 2024 reduction was CVS Health, cutting an estimated $2.06M.
  • Core Alternative Capital fully exited Gabelli Dividend & Income Trust 5.375% Series H Preferred Shares in Q3 2024, selling an estimated $17.5K.
  • Core Alternative Capital's ten largest holdings make up 32% of its $517M portfolio in Q3 2024.
  • Core Alternative Capital opened 4 new positions and closed 6 in Q3 2024.
  • Core Alternative Capital's portfolio value rose 3.4% quarter-over-quarter to $517M.

Based on Core Alternative Capital's 13F filing for Q3 2024, filed 14 Nov 2024.